A new drug approved for treatment of 'off phenomenon' in Parkinsonism:: (A) Safinamide, (B) Evenamide, (C) Lacosamide, (D) Ziconotide
Answer is A. Safinamide: Orally active Selective, reversible monoamine oxidase-B inhibitor with both dopaminergic and non-dopaminergic (glutamatergic) propeies.